Entest Group Inc

[hookem]

Can you explain the relationship with Zander and how Regen BIOPharma effects this.
I just own shares of ENTB on a dice role.

Wanting to learn more.... I do not understand the following...

"Regen is also party to an agreement whereby Zander Therapeutics, Inc. has been granted by Regen, an exclusive worldwide right and license for the development and commercialization of NR2F6 intellectual property controlled by Regen for non-human veterinary therapeutic use. Zander Therapeutics Inc. is a wholly-owned subsidiary of Entest BioMedical Inc. (PINKS: ENTB). David R. Koos serves as Chairman and Chief Executive Officer of Regen, Entest Biomedical, Inc. and Zander Therapeutics."